Sirtuin 1 Activity in Peripheral Blood Mononuclear Cells of Patients with Osteoporosis
暂无分享,去创建一个
W. Abbas | K. Khan | G. Herbein | C. Prati | D. Wendling | E. Toussirot | M. Godfrin-Valnet | X. Guillot | L. Baud
[1] W. Abbas,et al. Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha Production , 2013, PloS one.
[2] W. Abbas,et al. Resveratrol, a sirtuin 1 activator, increases IL-6 production by peripheral blood mononuclear cells of patients with knee osteoarthritis , 2013, Clinical Epigenetics.
[3] E. Lespessailles,et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. , 2012, Joint, bone, spine : revue du rhumatisme.
[4] G. Schett,et al. Pathways for Bone Loss in Inflammatory Disease , 2012, Current Osteoporosis Reports.
[5] C. Cooper,et al. Epigenetic influences in the developmental origins of osteoporosis , 2012, Osteoporosis International.
[6] M. Yen,et al. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] D. Toiber,et al. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. , 2011, Endocrinology.
[8] A. Mobasheri,et al. Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells , 2011, The Journal of Biological Chemistry.
[9] G. Andersson,et al. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. , 2010, Biochemical and biophysical research communications.
[10] G. Herbein,et al. Histone deacetylases in viral infections , 2010, Clinical Epigenetics.
[11] P. Tak,et al. Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on? , 2008, Arthritis research & therapy.
[12] K. Shimamoto,et al. Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1* , 2007, Journal of Biological Chemistry.
[13] C. Bäckesjö,et al. Activation of Sirt1 Decreases Adipocyte Formation During Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] S. Renaud,et al. Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.